In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wake-up Calls in IVD

Executive Summary

Inverness Medical Innovations and Beckman Coulter are currently in a bidding war for Biosite and its point of care BNP test. The fight is just one example of the demand for innovative diagnostic test content. The recent upswing in IVD deal-making, along with renewed VC interest in diagnostics, suggests that the area's potential to drive health care innovation by directing therapy more efficiently is finally being recognized.
Advertisement

Related Content

Is Diagnostics the New Biotech...and Will Pharma Embrace It?
Leveraging Assay Platforms to Create Category-Killer Diagnostic Tests
Medical Device and In Vitro Diagnostics Deal Statistics Quarterly, Q2 2007
Siemens--Stealing GE's Thunder
Does Roche Have It Right?
Inverness Buys Bulk
What's Next for Abbott in IVD?
Deal Statistics Quarterly, Q1 2007
Genomics and Proteomics Forays into Psychiatric Illness
GE Grabs the Spotlight in IVD

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002936

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel